MedPath
NMPA Approval

Poliomyelitis (Live) Vaccine (Human Diploid Cell), Oral

国药准字S20130001

March 23, 2023

Drug Information

口服脊髓灰质炎减毒活疫苗(人二倍体细胞)

口服溶液剂

每瓶1.0ml。每1次人用剂量为2滴(相当于0.1ml),所含脊髓灰质炎活病毒总量应不低于6.25lgCCID50,其中I型应不低于6.0lgCCID50,Ⅱ型应不低于5.0lgCCID50,Ⅲ型应不低于5.8lgCCID50。

生物制品

March 23, 2023

Company Information

Applicant Company

北京市北京经济技术开发区博兴二路9号院4号楼2层205室

Manufacturing Company

北京市北京经济技术开发区博兴二路6、9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

口服脊髓灰质炎减毒活疫苗(人二倍体细胞) - NMPA 批准文号 | MedPath